INGRAM ROBERT ALEXANDER

CIK 000121989018 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001219890

Recent Transactions

50 trades

Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-02-28$8.85/sh+2,259→ 100,198 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-12-16$1.50/sh+9,375→ 42,854 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-11-30$13.36/sh+1,497→ 97,939 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-09-16$2.62/sh+6,584→ 33,479 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-08-31$13.90/sh+1,438→ 96,442 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-06-17$2.03/sh+8,498→ 26,895 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2022-06-10+15,000→ 15,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2022-06-07+30,022→ 30,022 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-06-07+12,866→ 95,004 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-05-31$9.31/sh+2,078→ 82,138 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2022-03-18$3.02/sh+5,795→ 18,397 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-02-28$16.61/sh+1,128→ 80,060 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-12-17$5.31/sh+3,296→ 12,602 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-11-30$12.06/sh+1,554→ 78,932 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-09-17$9.90/sh+1,869→ 9,306 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-08-31$15.92/sh+1,177→ 77,378 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-06-18$12.95/sh+1,255→ 7,437 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2021-06-18+15,000→ 15,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-28$15.77/sh+1,188→ 76,201 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2021-05-25+40,000→ 40,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2021-03-18$24.01/sh+677→ 6,182 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-02-26$10.78/sh+1,739→ 75,013 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-12-15$34.29/sh+505→ 5,505 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-11-30$5.11/sh+3,669→ 73,274 total
Purchase
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2020-09-30$30.46/sh+5,000→ 5,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2020-09-25+29,842→ 29,842 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-08-31$4.15/sh+4,518→ 69,605 total
Award
NVN Liquidation, Inc.
Stock Option (Right to Buy)
2020-07-28+20,000→ 20,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-06-01$4.50/sh+4,171→ 65,087 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2020-05-12+40,000→ 40,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-03-01$3.00/sh+6,250→ 60,916 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-12-01$2.85/sh+6,578→ 54,666 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-11-18$1.45/sh+20,000→ 48,088 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-09-01$2.99/sh+6,270→ 28,088 total
Award
NVN Liquidation, Inc.
Stock Option (Right to Buy)
2019-07-31+20,000→ 20,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2019-05-29+30,000→ 30,000 total
Purchase
NVN Liquidation, Inc.
Common Stock
2019-05-22$2.21/sh+50,000→ 169,777 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−41,414→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
2018-10-22−4,846→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+150,612→ 150,612 total
Conversion
PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
2018-10-22−3,862→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−226,061→ 0 total
Purchase
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22$5.00/sh+12,487→ 163,099 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
2018-10-22−4,309→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−149,320→ 0 total
Exercise of In-Money
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22$0.12/sh+4,309→ 13,662 total
Sale
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$5.00/sh−42→ 94,874 total
Conversion
PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
2018-10-22−40,420→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
2018-10-22−24,709→ 0 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+1,683,420→ 1,683,420 total

Companies

Recent Filings

Address

2525 DUPONT DRIVE

IRVINE, CA, 92612

View on SEC.gov